Cardiol Therapeutics Inc (CRDL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 26 | 25 | 25 | 48 | 201 |
| Accounts receivable | 84 | 67 | 15 | -95 | -24 |
| Other Working Capital | -622 | 671 | -152 | 990 | -2,673 |
| Other Operating Activity | -6,412 | -5,314 | -7,042 | -6,537 | -5,273 |
| Operating Cash Flow | $-6,925 | $-4,551 | $-7,154 | $-5,593 | $-7,769 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | -6 | -12 | -6 | -8 |
| Investing Cash Flow | $-3 | $-6 | $-12 | $-6 | $-8 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -14 | -14 | -14 | -14 | -5 |
| Other Financing Activity | 0 | 34 | 0 | 18,704 | 0 |
| Financing Cash Flow | $-14 | $20 | $-14 | $18,691 | $-5 |
| Exchange Rate Effect | 369 | -561 | -108 | 1,604 | -355 |
| Beginning Cash Position | 18,195 | 23,293 | 30,580 | 15,885 | 24,021 |
| End Cash Position | 11,622 | 18,195 | 23,293 | 30,580 | 15,885 |
| Net Cash Flow | $-6,942 | $-4,537 | $-7,180 | $13,091 | $-7,782 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,925 | -4,551 | -7,154 | -5,593 | -7,769 |
| Capital Expenditure | -3 | -6 | -12 | -6 | -8 |
| Free Cash Flow | -6,928 | -4,557 | -7,166 | -5,599 | -7,777 |